Shuli Li

11.9k total citations · 1 hit paper
239 papers, 6.9k citations indexed

About

Shuli Li is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Shuli Li has authored 239 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 50 papers in Cell Biology and 44 papers in Oncology. Recurrent topics in Shuli Li's work include melanin and skin pigmentation (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Head and Neck Cancer Studies (19 papers). Shuli Li is often cited by papers focused on melanin and skin pigmentation (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Head and Neck Cancer Studies (19 papers). Shuli Li collaborates with scholars based in United States, China and Italy. Shuli Li's co-authors include Chunying Li, Michael T. Longaker, Natalina Quarto, Tianwen Gao, Jianru Chen, Robert J. Soiffer, Zhe Jian, Yinghan Wang, Xiuli Yi and Benjamin Lévi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shuli Li

226 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Shuli Li

Since Specialization

Citations

This map shows the geographic impact of Shuli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Li more than expected).

Fields of papers citing papers by Shuli Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Li. The network helps show where Shuli Li may publish in the future.

Co-authorship network of co-authors of Shuli Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuli Li. A scholar is included among the top collaborators of Shuli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuli Li. Shuli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation 2024 ·European Journal of Medicinal Chemistry ·Xiaoqing Gong, Shuli Li, Junli Huang, Shuoyan Tan, (unknown), Yanan Tian, Qin Li, Lingling Wang, Henry H. Y. Tong, Xiaojun Yao, Chunxia Chen, Simon Ming‐Yuen Lee, Huanxiang Liu	5
2	From mice to men: An assessment of preclinical model systems for the study of vitiligo 2024 ·Clinical Immunology ·Wei Wu, (unknown), (unknown), Chunying Li, Shuli Li	2
3	Circulating memory T cells and TCF1+ T cells aid in diagnosis and monitor disease activity in vitiligo 2024 ·Journal of Pharmaceutical Analysis ·(unknown), Jianru Chen, Wei Wu, (unknown), (unknown), Weiwei Sun, (unknown), Shuli Li, Chunying Li	2
4	Changes in epidermal thickness and their correlation with clinical characteristics in patients with vitiligo 2024 ·Archives of Dermatological Research ·(unknown), Weiwei Sun, (unknown), (unknown), (unknown), Shuli Li	1
5	TRPM2 ‐dependent autophagy inhibition exacerbates oxidative stress‐induced CXCL16 secretion by keratinocytes in vitiligo 2024 ·The Journal of Pathology ·Pan Kang, Yinghan Wang, Jianru Chen, Yuqian Chang, Weigang Zhang, Tingting Cui, Xiuli Yi, Shuli Li, Chunying Li	9
6	Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo 2023 ·Journal of Translational Medicine ·Yuqian Chang, Pan Kang, Tingting Cui, Weinan Guo, Weigang Zhang, (unknown), Xiuli Yi, Sen Guo, Tianwen Gao, Chunying Li, Shuli Li	19
7	MIF inhibition alleviates vitiligo progression by suppressing CD8⁺ T cell activation and proliferation 2023 ·The Journal of Pathology ·Jianru Chen, Weinan Guo, (unknown), Tingting Cui, Yuqi Yang, Yinghan Wang, Pan Kang, Zhe Zhang, Qi Wang, (unknown), Ling Liu, Zhe Jian, Tianwen Gao, Huijie Bian, Shuli Li, Chunying Li	9
8	Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo 2022 ·Cell Death Discovery ·Pan Kang, Jianru Chen, Weigang Zhang, Ningning Guo, Xiuli Yi, Tingting Cui, Jiaxi Chen, Yuqi Yang, Yinghan Wang, (unknown), (unknown), (unknown), Chunying Li, Shuli Li	46
9	Macrophage TGF-β signaling is critical for wound healing with heterotopic ossification after trauma 2022 ·JCI Insight ·Nicole Patel, Johanna Nunez, Michael Sorkin, Simone Marini, Chase A. Pagani, Amy L. Strong, Charles Hwang, Shuli Li, Karthik Padmanabhan, Ravi Kumar, (unknown), (unknown), (unknown), (unknown), (unknown), Kaetlin Vasquez, Amanda K. Huber, Benjamin Lévi	25
10	HSF1-Dependent Autophagy Activation Contributes to the Survival of Melanocytes Under Oxidative Stress in Vitiligo 2021 ·Journal of Investigative Dermatology ·Tingting Cui, Yinghan Wang, Pu Song, Xiuli Yi, Jiaxi Chen, Yuqi Yang, Huina Wang, Pan Kang, Sen Guo, Ling Liu, Kai Li, Zhe Jian, Shuli Li, Chunying Li	21
11	RIP1-Mediated Necroptosis Facilitates Oxidative Stress‒Induced Melanocyte Death, Offering Insight into Vitiligo 2021 ·Journal of Investigative Dermatology ·(unknown), Xiuli Yi, (unknown), Shaolong Zhang, Shuli Li, Yuqi Yang, Tingting Cui, Jiaxi Chen, Yuqian Chang, Tianwen Gao, Chunying Li, Ling Liu	13
12	Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo 2021 ·Clinical Reviews in Allergy & Immunology ·Yinghan Wang, Shuli Li, Chunying Li	60
13	Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131) 2020 ·Clinical Cancer Research ·Douglas B. Johnson, Fengmin Zhao, Marcus Smith Noel, Gregory J. Riely, Edith P. Mitchell, James R. Wright, Helen X. Chen, Robert J. Gray, Shuli Li, Lisa M. McShane, Larry Rubinstein, David R. Patton, (unknown), (unknown), Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	42
14	Mechanisms of melanocyte death in vitiligo 2020 ·Medicinal Research Reviews ·Jianru Chen, Shuli Li, Chunying Li	180
15	Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion 2020 ·Cell Death and Disease ·(unknown), Xiuli Yi, Jianru Chen, Pan Kang, Xuguang Chen, Jiaxi Chen, Tingting Cui, Yuqian Chang, (unknown), (unknown), Yinghan Wang, (unknown), (unknown), Ling Liu, Zhe Jian, Kai Li, Tianwen Gao, Shuli Li, Chunying Li	19
16	E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group breakdown → 2017 ·Journal of Clinical Oncology ·Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, David R. Trevarthen, (unknown), Barbara A. Murphy, Nishant Agrawal, A. Dimitrios Colevas, Christine H. Chung, Barbara Burtness	317
17	Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification 2015 ·Proceedings of the National Academy of Sciences ·Shailesh Agarwal, Shawn Loder, Cameron Brownley, David Cholok, Laura Mangiavini, John Li, Christopher Breuler, Hsiao Hsin Sung, Shuli Li, Kavitha Ranganathan, Joshua M. Peterson, Ronald G. Tompkins, David N. Herndon, Wenzhong Xiao, Dolrudee Jumlongras, Bjørn R. Olsen, Thomas A. Davis, Yuji Mishina, Ernestina Schipani, Benjamin Lévi	172
18	Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells 2011 ·Proceedings of the National Academy of Sciences ·Natalina Quarto, Brian C. Leonard, Shuli Li, Mélanie Marchand, Erica Anderson, Barry Behr, Uta Francke, Renee A. Reijo Pera, Eric Chiao, Michael T. Longaker	59
19	Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494 2010 ·Clinical Cancer Research ·Jane N. Winter, Shuli Li, (unknown), Daina Variakojis, Beverly P. Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie Weller, Ari Melnick, John C. Reed, Sandra J. Horning, Randy D. Gascoyne	26
20	Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis 2009 ·Cancer Research ·Samuel L. Volchenboum, Cheng Li, Shuli Li, Edward F. Attiyeh, C. Patrick Reynolds, John M. Maris, A. Thomas Look, Rani E. George	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact